UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ZLAB — Zai Lab Ltd
CIK 861177
NEW YORK, NY
Position in ZLAB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,812
+$9,043 QoQ
Shares Held
628
+300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. ZLAB ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in ZLAB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,812 | 628 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,769 | 157 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $183,592 | 5,250 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,368 | 1,200 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,495,815 | 57,114 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,349,763 | 55,914 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $968,989 | 55,914 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $291,099 | 18,171 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $368,025 | 13,466 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $323,760 | 13,318 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,708,600 | 458,298 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,242,987 | 458,298 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,781,421 | 416,333 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,276,890 | 417,453 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,403,712 | 415,332 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,525,035 | 421,215 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,283,434 | 434,104 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $42,329,365 | 401,645 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $67,824,337 | 383,210 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,340,086 | 362,288 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $48,649,720 | 359,463 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $19,407,801 | 233,351 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $12,981,877 | 158,065 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,086,224 | 98,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||